top of page
IMMUNOTHERAPY
The Future of Medicine
Antiviral Immunotherapy
Pioneering Immunotherapy for Viral & Oncology Indications
ANTIVIRAL IMMUNOTHERAPY
Immunotherapy is 21st century medicine. Immunacor harnesses the innate immune response to mitigate viral load & increase adaptive immunity. Immunacor enters Phase 1 clinical trials Q3-Q4 2020.
ONCOLOGY
Immuno-oncology is at the forefront of cancer therapy. Immunacor's immunotherapy can activate the immune system against cancer and will be entering Phase 1 Clinical Trials Q1 2021.
bottom of page